4.5 Review

FOXP1: a potential therapeutic target in cancer

期刊

EXPERT OPINION ON THERAPEUTIC TARGETS
卷 11, 期 7, 页码 955-965

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.11.7.955

关键词

3p; forkhead; Foxp1; lymphoma; oncogene; transcription factor; turnout suppressor

资金

  1. NCI NIH HHS [CA31534, K08 CA096876, R01 CA092318, 1F32CA110624-01A1] Funding Source: Medline

向作者/读者索取更多资源

Forkhead Box P1 (FOXP1) is a member of the FOX family of transcription factors which have a broad range of functions. Foxp1 is widely expressed and has been shown to have a role in cardiac, lung and lymphocyte development. FOXP1 is targeted by recurrent chromosome translocations and its overexpression confers a poor prognosis in a number of types of lymphomas, suggesting it may function as an oncogene. In contrast, FOXP1 localises to a tumour suppressor locus at 3p14.1 and loss of FOXP1 expression in breast cancer is associated with a worse outcome, suggesting FOXP1 may function as a tumour suppressor in other tissue types. These data suggest that FOXP1 may not only be useful in prognosis but also may be used to develop FOXP1-directed therapeutic strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据